SEC Form 4 research
| Issuer | CYTOMEDIX INC |
|---|---|
| Tickers | CMXI, GTF, CMXI.OB, NUOT, AURX, CTF, GFT |
| Reporting owners | 30 |
| Officers and directors | 10 |
| Last public filing | 2026-10-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-06 | Pittman Scott M. | A | 458 | $1.5 | Not reported |
| 2026-10-06 | 2026-10-06 | Pittman Scott M. | A | 4,500 | $1.5 | Not reported |
| 2026-08-31 | 2026-08-28 | JORDEN DAVID EMERSON | P | 7,984 | $1.09 | Not reported |
| 2026-08-31 | 2026-08-27 | JORDEN DAVID EMERSON | P | 789 | $1.07 | Not reported |
| 2026-08-28 | 2026-08-28 | JORDEN DAVID EMERSON | A | 7,984 | $1.09 | Not reported |
| 2026-08-28 | 2026-08-27 | JORDEN DAVID EMERSON | A | 789 | $1.07 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.